SG Americas Securities’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251K Sell
10,733
-281,692
-96% -$5.1M ﹤0.01% 2538
2025
Q4
$4.15M Buy
292,425
+256,669
+718% +$4.86M 0.01% 1162
2025
Q3
$885K Buy
+35,756
New +$798K ﹤0.01% 1577
2025
Q2
Sell
-22,260
Closed -$675K 2878
2025
Q1
$675K Sell
22,260
-88,606
-80% -$3.38M ﹤0.01% 1527
2024
Q4
$4.4M Buy
110,866
+97,235
+713% +$4.39M 0.02% 377
2024
Q3
$864K Sell
13,631
-4,596
-25% -$332K ﹤0.01% 1200
2024
Q2
$1.23M Buy
18,227
+14,824
+436% +$1.04M 0.01% 1209
2024
Q1
$270K Sell
3,403
-4,884
-59% -$399K ﹤0.01% 1755
2023
Q4
$644K Sell
8,287
-9,433
-53% -$698K 0.01% 1305
2023
Q3
$1.25M Sell
17,720
-7,778
-31% -$581K 0.01% 1094
2023
Q2
$2.03M Sell
25,498
-7,021
-22% -$507K 0.02% 736
2023
Q1
$2.35M Buy
32,519
+13,018
+67% +$1.01M 0.03% 579
2022
Q4
$1.6M Buy
19,501
+11,903
+157% +$981K 0.02% 662
2022
Q3
$594K Sell
7,598
-12,610
-62% -$1.01M 0.01% 1389
2022
Q2
$1.37M Sell
20,208
-21,159
-51% -$1.48M 0.01% 1021
2022
Q1
$2.71M Buy
41,367
+8,065
+24% +$469K 0.02% 715
2021
Q4
$2.02M Buy
33,302
+1,939
+6% +$116K 0.01% 1075
2021
Q3
$2M Buy
31,363
+10,390
+50% +$656K 0.01% 1268
2021
Q2
$1.32M Buy
20,973
+6,713
+47% +$421K 0.01% 1379
2021
Q1
$815K Sell
14,260
-32,595
-70% -$1.76M ﹤0.01% 1679
2020
Q4
$2.35M Buy
46,855
+35,925
+329% +$1.43M 0.01% 990
2020
Q3
$322K Sell
10,930
-14,182
-56% -$412K ﹤0.01% 1894
2020
Q2
$631K Sell
25,112
-26,774
-52% -$668K 0.01% 1865
2020
Q1
$952K Buy
51,886
+22,590
+77% +$647K 0.01% 1334
2019
Q4
$973K Buy
29,296
+2,753
+10% +$86.3K 0.01% 1282
2019
Q3
$825K Sell
26,543
-5,428
-17% -$165K 0.01% 1529
2019
Q2
$1.12M Buy
31,971
+22,988
+256% +$743K 0.01% 1356
2019
Q1
$263K Buy
8,983
+368
+4% +$10.4K ﹤0.01% 2375
2018
Q4
$221K Sell
8,615
-4,444
-34% -$154K ﹤0.01% 2333
2018
Q3
$460K Buy
13,059
+700
+6% +$27.9K ﹤0.01% 2151
2018
Q2
$506K Sell
12,359
-2,411
-16% -$97.2K ﹤0.01% 1998
2018
Q1
$579K Sell
14,770
-21,120
-59% -$774K ﹤0.01% 1775
2017
Q4
$1.17M Buy
35,890
+31,408
+701% +$1.09M 0.01% 1263
2017
Q3
$214K Sell
4,482
-1,181
-21% -$57.6K ﹤0.01% 2531
2017
Q2
$280K Buy
+5,663
New +$251K ﹤0.01% 2204
2017
Q1
Sell
-4,974
Closed -$165K 3240
2016
Q4
$165K Buy
+4,974
New +$193K ﹤0.01% 2497
2015
Q4
Sell
-4,657
Closed -$309K 2681
2015
Q3
$309K Buy
+4,657
New +$358K ﹤0.01% 1236
2015
Q2
Sell
-4,400
Closed -$315K 2589
2015
Q1
$315K Buy
+4,400
New +$282K ﹤0.01% 1662
2014
Q4
Sell
-2,393
Closed -$116K 3151
2014
Q3
$116K Sell
2,393
-2,405
-50% -$118K ﹤0.01% 2291
2014
Q2
$218K Buy
4,798
+2,104
+78% +$92.5K ﹤0.01% 1995
2014
Q1
$122K Buy
+2,694
New +$133K ﹤0.01% 2150
2013
Q4
Sell
-7,332
Closed -$289K 2623
2013
Q3
$289K Buy
+7,332
New +$272K ﹤0.01% 1938

Other funds holding ACHC

SG Americas Securities's ACHC Position: Q1 2026 in Review

SG Americas Securities reduced its Acadia Healthcare (ACHC) stake by 96% in Q1 2026, selling an estimated $5.1M and leaving 10,733 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #2538.

SG Americas Securities first reported a position in ACHC in Q3 2013 and has held it in 42 quarters since. The position peaked at $4.4M in Q4 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • SG Americas Securities held 10,733 shares of Acadia Healthcare worth $251K as of Q1 2026.
  • SG Americas Securities sold 281,692 Acadia Healthcare shares in Q1 2026, an estimated $5.1M.
  • Acadia Healthcare made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2538 holding.
  • SG Americas Securities first reported a position in Acadia Healthcare in Q3 2013 and has held it in 42 quarters since.
  • SG Americas Securities's Acadia Healthcare position peaked at $4.4M in Q4 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.